Halozyme Therapeutics, Inc. Third Quarter Financial & Operating Results NASDAQ: HALO November 3, 2025 1 Forward-Looking Statements In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future financial performance and growth rates (including the Company's 2025 financial guidance and longer term financial outlook through 2028 and the assumptions used in deriving such g ...

Empowering people, informing care decisions November 2025 ©2025 Castle Biosciences 1 Disclaimers Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements concerning: our positioning for continued grow ...

Champions of Women's Health Q4'25 Corporate Presentation Safe Harbor Statement This presentation contains forward-looking information that involves risks and uncertainties, including statements about the Company's plans, objectives, expectations and intentions. Such statements include, without limitation: financial or other information based upon or otherwise incorporating judgments or estimates relating to future performance, events or expectations; the Company's strategies, positioning, resources, capabil ...

© 2025 Solid Biosciences November 2025 SGT-003 INSPIRE DUCHENNE DATA UPDATE Cautionary Note Regarding Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding future expectations, plans and prospects for the company; the ability to successfully achieve and execute on the company's goals, priorities and key clinical and preclinical milestones; strategies and expectations for th ...

Company Overview - STRATTEC was founded in 1908 and went public in 1995, with a market capitalization of $277 million as of October 28, 2025 [5] - Institutional ownership is 76%, while insider ownership is 3.6% [5] - The company's revenue for the trailing twelve months (TTM) ending Q1 FY26 was $578.4 million [9] - The company provides highly engineered products for leading OEMs, with sales by product including Door Handles (25%), Power Access (25%), Keys & Locksets (18%), Latches (13%), Other (11%), and Aftermarket (8%) [8, 9] Financial Performance - Revenue has steadily increased from $492.9 million in FY2023 to $578.4 million in TTM Q1 FY26 [14] - Cash from operations has improved significantly, reaching $71.7 million in FY2025 and TTM Q1 FY26 [14] - Gross profit has risen from $42.2 million in FY2023 to $92.0 million in TTM Q1 FY26 [17] - Q1 FY26 net sales increased by $13.3 million, or 9.6%, to $152.4 million compared to $139.1 million in Q1 FY25 [35, 36] - Q1 FY26 gross margin expanded by 370 basis points year-over-year [44] - Net income attributable to STRATTEC was up 130% year-over-year in Q1 FY26 [49] Strategic Initiatives - The company reduced headcount by 15% in FY25, resulting in $5 million in savings [12] - The company captured $8 million in annualized pricing in FY2025 [12] - The company signed a new $40 million revolving credit facility in October 2025, extending the maturity to 2028 [61]

Financial Performance & Guidance - The company projects 2025 adjusted gross margin to be between $3.21 billion and $3.28 billion[8] - The company anticipates 2025 EPS guidance to be between $4.90 and $5.10[8] - The company projects 2026 adjusted gross margin to be between $3.31 billion and $3.37 billion[11] - The company anticipates 2026 EPS guidance to be between $4.55 and $4.75[11] - The company targets long-term EPS growth of 5%-7% off original 2024 midpoint[12] Capital Investments & Rate Base - The company plans a total APS capital investment of $10.35 billion from 2025-2028[15] - The company projects the ACC rate base to be $15.7 billion in 2028[17] - The company projects the FERC rate base to be $4.0 billion in 2028[17] Regulatory & Operational Highlights - The company's 2025 rate case requests a net revenue increase of $580 million, impacting customers by 13.99% on day 1[40] - The company expects core O&M to remain flat with a rapidly growing customer base[23] - The company estimates cash from operations to be approximately $3.8 billion and total capital investment to be between $2.6 billion and $2.9 billion[25] Sales Growth - The company expects weather-normalized retail electricity sales growth of 4%-6% in 2026, including 3%-5% from large C&I customers[12] - The company's residential customer growth is projected to be 1.5%-2.5% in 2026[12]

Production and Operations - Third quarter net production was approximately 65,500 boepd[10] - Ghana's third quarter net production reached approximately 31,300 boepd[10] - Mauritania & Senegal's third quarter net production was approximately 11,400 boepd[10] - Gulf of America's third quarter net production was approximately 16,600 boepd[10] - Equatorial Guinea's third quarter net production was approximately 6,200 bopd[10] Financial Performance and Cost Management - The company is on track to achieve fiscal year 2025 capex of less than $350 million, a year-on-year reduction of approximately $500 million[9] - Operating costs decreased by approximately 39% quarter-over-quarter[9] - The company is on track to deliver a targeted $25 million overhead reduction by year-end 2025[9] - Third quarter 2025 opex was approximately $19.5/boe, compared to approximately $28.2/boe in the second quarter of 2025[25] Balance Sheet and Liquidity - The company completed a $250 million Gulf of America term loan[9] - The company repaid $150 million of 2026 notes[9] - The company has hedged 8.5 million barrels for 2026[9]

Financial Performance - PSEG's Q3 2025 Net Income was $1.24 per share, and Year-to-Date (YTD) Net Income was $3.59 per share[12] - Q3 2025 non-GAAP Operating Earnings were $1.13 per share, and YTD non-GAAP Operating Earnings were $3.33 per share, representing increases of approximately 26% and 17% respectively[12] - PSEG narrows 2025 non-GAAP Operating Earnings guidance to $4.00 - $4.06 per share (from $3.94 - $4.06 per share prior)[15] - PSE&G filed annual transmission formula rate update with FERC in October, resulting in approximately $82 million in increased annual transmission revenue effective January 1, 2026, subject to true-up[29] Capital Investment and Spending - PSE&G invested approximately $1 billion in Q3 2025 and approximately $2.7 billion YTD as part of a full-year 2025 regulated capital spending plan of approximately $3.8 billion[12, 29] - The company has a regulated capital investment program for 2025-2029 of $21 billion - $24 billion, driven by infrastructure modernization, energy efficiency, and growing customer demand[12] - Total PSEG capital program of $22.5 billion - $26 billion for 2025-2029[15] Operational Highlights - PSE&G effectively maintained high system reliability and efficient customer response times, restoring all impacted electric customers within 24 hours and over 200 gas services within a four-day period, following a July NJ state of emergency caused by a severe storm and flooding[12] - PSE&G replaced year-to-date approximately 170 miles of gas main and approximately 22,000 associated gas services to homes and businesses as scheduled under the gas main replacement program[29] - PSE&G large load inquires for new service connections rose to approximately 11,500 megawatts as of September 30, 2025[29] Nuclear Generation - Hope Creek completed a breaker-to-breaker run, operating for 499 continuous days since its last refueling outage, and recently completed work to extend its fuel cycle from 18 to 24 months[12, 34] - For 2025, total nuclear generation is forecasted to be 30-32 TWh[34]

Agenda Agenda | | | Corporate Outlook Dennis Hom Q&A ENTERING THE CLINIC WITH AX-0810 Establishing safety, PK, and the biomarker roadmap for proof of target engagement November 3, 2025 Strategic Overview Daniel A. de Boer AX-0810 Lead Pipeline Program in Liver Cristina Lopez Lopez Henkjan Verkade Daniel A. de Boer Cristina Lopez Lopez Gerard Platenburg Dennis Hom Cristina Lopez Lopez, MD, PhD Chief Medical Officer Dennis Hom Chief Financial Officer Gerard Platenburg Chief Scientific Officer Speakers Invited ...

Transaction Overview - The transaction involves a combination of SM Energy and Civitas Resources, with an enterprise value of approximately $12.8 billion[10] - The deal is a stock-for-stock transaction, with 1.45 shares of SM Energy exchanged for each share of Civitas[10] - Pro forma ownership will be 48% for SM Energy and 52% for Civitas[10, 12] Scale and Portfolio - The combined company will have approximately 823,000 net acres across key U.S shale basins[13] - Q2'25 net production is estimated at 526 Mboe/d for the pro forma entity[13] - Year-end 2024 estimated net proved reserves are projected to be 1,476 MMBoe[13] Synergies and Financial Impact - The merger aims to achieve annual run-rate synergies of approximately $200 million to $300 million by 2027[30, 42] - Synergies are expected to come from overhead/G&A, D&C/Operational costs, and cost of capital efficiencies[30] - The combined company will prioritize debt reduction, targeting a 1.0x net leverage ratio by year-end 2027, assuming $65 NYMEX WTI and $3.50 Henry Hub prices[32, 33]